{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"description":"PK: Average Concentration at Steady State of LY3499446 in Combination with Cetuximab","groups":[{"description":"LY3499446 in combination with cetuximab intravenously (IV).","id":"OG000","title":"LY3499446 and Cetuximab Phase 1"}],"populationDescription":"Zero participants were analyzed due to early termination of study.","reportingStatus":"POSTED","timeFrame":"Predose Cycle 1 Day 1 through Cycle 3 Day 1 (21 Day Cycles)","title":"Phase 1: PK: Average Concentration at Steady State of LY3499446 in Combination With Cetuximab","type":"SECONDARY"}